HESTERBIO

HESTER BIOSCIENCES

Small Cap BSE: 524669 NSE: HESTERBIO
₹2002.75
-18.9 (-0.93%)
  • Advice
  • Hold
As on 30 September, 2022 | 03:24

Hester Biosciences Share Price

Hester Biosciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in HESTER BIOSCIENCES

Start SIP

Hester Biosciences Share Returns

  • Over 1 Month -4.41%
  • Over 3 Month -2.73%
  • Over 6 Month -23.27%
  • Over 1 Year -19.29%

Hester Biosciences Key Statistics

P/E Ratio 55.3
PEG Ratio -2.2
Market Cap Cr 1,704
Price to Book Ratio 6.4
EPS 46.3
Dividend 0.5
Relative Strength Index 42.73
Money Flow Index 78.01
MACD Signal -28.49
Average True Range 85.34

Hester Biosciences Investment Rating

  • Master Rating:
  • Hester Biosciences has an operating revenue of Rs. 225.51 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 23% is great, ROE of 15% is good. The company has a debt to equity of 63%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 51 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Hester Biosciences Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 515054575963
Operating Expenses Qtr Cr 414039394043
Operating Profit Qtr Cr 91015171821
Depreciation Qtr Cr 232222
Interest Qtr Cr 110000
Tax Qtr Cr 223444
Net Profit Qtr Cr 551112129

Hester Biosciences Technicals

EMA & SMA

Current Price
2002.75
-18.9 (-0.93%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 2084.19
  • 50 Day
  • 2139.73
  • 100 Day
  • 2206.84
  • 200 Day
  • 2344.21
  • 20 Day
  • 2091.06
  • 50 Day
  • 2158.32
  • 100 Day
  • 2198.57
  • 200 Day
  • 2345.78

Hester Biosciences Resistance and Support

PIVOT
₹2024.27
Resistance
First Resistance 2045.39
Second Resistance 2069.12
Third Resistance 2090.24
RSI 42.73
MFI 78.02
MACD Single Line -28.49
MACD -32.83
Support
First Resistance 2000.54
Second Resistance 1979.42
Third Resistance 1955.69

Hester Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 5,096 255,717 50.18
Week 70,712 987,140 13.96
1 Month 20,293 455,585 22.45
6 Month 9,014 368,505 40.88

Hester Biosciences Result Highlights

Hester Biosciences Synopsis

NSE-Medical-Ethical Drugs

Hester Biosciences L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 219.35 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2022. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.
Market Cap 1,704
Sales 211
Shares in Float 0.39
No of funds 19
Yield 0.5
Book Value 6.35
U/D Vol ratio 2
LTDebt / Equity 27
Alpha -0.06
Beta 0.39

Hester Biosciences

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 53.73%53.73%53.73%
Mutual Funds 0.03%0.03%0.02%
Foreign Portfolio Investors 0.72%0.92%0.8%
Financial Institutions/ Banks
Individual Investors 32.61%31.93%31.98%
Others 12.91%13.39%13.47%

Hester Biosciences Management

Name Designation
Dr. Bhupendra Gandhi Chairman
Mr. Rajiv Gandhi Managing Director & CEO
Ms. Priya Gandhi Executive Director
Mr. Ravin Gandhi Director
Mr. Sanjiv Gandhi Director
Mr. Ashok Bhadakal Independent Director
Mr. Naman Patel Independent Director
Mr. Amit Shukla Independent Director
Mr. Sandhya Patel Independent Director
Mr. Ameet Desai Independent Director
Ms. Nina Gandhi Alternate Director

Hester Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Hester Biosciences Corporate Action

Date Purpose Remarks
2022-08-10 Quarterly Results
2022-05-20 Audited Results & Dividend
2022-01-31 Quarterly Results
2021-11-13 Others
2021-10-28 Quarterly Results

Hester Biosciences MF Shareholding

Name Amount(cr)
ITI Pharma and Healthcare Fund Regular Growth 165
Motilal Oswal S&P BSE Healthcare ETF 6

Hester Biosciences FAQs

What is Share Price of Hester Biosciences ?

Hester Biosciences share price is ₹2002 As on 30 September, 2022 | 03:10

What is the Market Cap of Hester Biosciences ?

The Market Cap of Hester Biosciences is ₹1703.7 Cr As on 30 September, 2022 | 03:10

What is the P/E ratio of Hester Biosciences ?

The P/E ratio of Hester Biosciences is 55.3 As on 30 September, 2022 | 03:10

What is the PB ratio of Hester Biosciences ?

The PB ratio of Hester Biosciences is 6.4 As on 30 September, 2022 | 03:10

Q1FY23